EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Survival prediction in sigmoid-Colon-cancer patients with liver metastasis: a prospective cohort study

Shuai Shao iD, Dan Tian iD, Mingyang Li iD, Shanshan Wu, Dong Zhang iD

JNCI Cancer Spectrum · 2024

DOI: 10.1093/jncics/pkae080 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Shuai Shao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Beijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Sigmoid Neoplasms, SEER Program, Proportional Hazards Models. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Beijing Postdoctoral Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Sigmoid colon cancer (SCC) is a common type of colorectal cancer, frequently leading to liver metastasis. Predicting cause-specific survival (CSS) and overall survival (OS) in SCC with liver metastasis (SCCLM) patients is challenging due to the lack of suitable models.

Methods

Data from SCCLM patients (2010-2017) in the Surveillance, Epidemiology, and End Results (SEER) Program were recruited. Patients were split into training and validation groups (7:3). Prognostic factors were identified using competing risk and Cox proportional hazards models, and nomograms for CSS and OS were developed. Model performance was evaluated with the concordance index and calibration curves, with a two-sided p < .05 was considered statistically significant.

Results

4,981 SCCLM patients were included, with a median follow-up of 20 months (IQR: 9-33 months). During follow-up, 72.25% of patients died (68.44% from SCC, 3.81% from other causes). Age, race, grade, T stage, N stage, surgery, chemotherapy, CEA, tumor deposits, lung metastasis, and tumor size were prognostic factors for both CSS and OS. The models demonstrated good discrimination and calibration performance, with C-index values of 0.79 (95% CI: 0.78-0.80) for CSS and 0.74 (95% CI: 0.73-0.75) for OS. A web-based application for real-time CSS predictions was created, accessible at https://shuaishao.shinyapps.io/SCCLM/.

Conclusion

Prognostic factors for SCCLM patients were identified basing on SEER database, and nomograms for CSS and OS showed good performance. A web-based application was developed to predict SCCLM-specific survival, aiding in survival risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsSigmoid NeoplasmsSEER ProgramProportional Hazards ModelsNomogramsHumansMaleFemaleProspective StudiesMiddle AgedAgedPrognosisNeoplasm StagingCarcinoembryonic AntigenTumor BurdenLung NeoplasmsAge FactorsNeoplasm Grading

Substanzen

Carcinoembryonic Antigen

Autor:innen und Institutionen

  • Department of Immunology, Beijing Clinical Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • General Surgery Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • National Clinical Research Center for Digestive Disease, Beijing, China.
  • Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Department of Immunology, Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • Department of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Shuai Shao, Dan Tian, Mingyang Li, Dong Zhang

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Beijing Postdoctoral Research Foundation

Zitieren

APA

Shao, S., Tian, D., Li, M., Wu, S., & Zhang, D. (2024). Survival prediction in sigmoid-Colon-cancer patients with liver metastasis: a prospective cohort study. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae080

Vancouver

Shao S, Tian D, Li M, Wu S, Zhang D. Survival prediction in sigmoid-Colon-cancer patients with liver metastasis: a prospective cohort study. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae080

BibTeX
@article{Shao2024,
  author = {Shao, Shuai and Tian, Dan and Li, Mingyang and Wu, Shanshan and Zhang, Dong},
  title = {Survival prediction in sigmoid-Colon-cancer patients with liver metastasis: a prospective cohort study},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  doi = {10.1093/jncics/pkae080}
}
Kostenlos starten →